BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19178978)

  • 1. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects.
    Li Y; Qiu LX; Shen XK; Lv XJ; Qian XP; Song Y
    Lung Cancer; 2009 Oct; 66(1):15-21. PubMed ID: 19178978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects.
    Zhou C; Chen H; Wang A
    Tumour Biol; 2013 Oct; 34(5):2961-9. PubMed ID: 23715779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians.
    Zhan P; Wang J; Zhang Y; Qiu LX; Zhao SF; Qian Q; Wei SZ; Yu LK; Song Y
    Lung Cancer; 2010 Jul; 69(1):19-25. PubMed ID: 19796841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.
    Pierce LM; Sivaraman L; Chang W; Lum A; Donlon T; Seifried A; Wilkens LR; Lau AF; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1199-204. PubMed ID: 11097227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
    Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.
    Jiang N; Pan J; Wang L; Duan YZ
    Tumour Biol; 2013 Feb; 34(1):587-96. PubMed ID: 23192640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 -251A/T gene polymorphism and lung cancer susceptibility: a meta-analysis.
    Wang XB; Li YS; Li J; Han Y; Liu ZD
    J Cell Mol Med; 2015 Jun; 19(6):1218-22. PubMed ID: 25817779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between p53 codon 72 polymorphism and sarcoma risk among Caucasians.
    Chang Z; Yu X
    Tumour Biol; 2014 May; 35(5):4807-12. PubMed ID: 24449505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the association between P53 codon 72 polymorphisms and gastric cancer.
    Zhang Q; Ma YY; Wang HJ; Shao CM; Zhang J; Ye ZY
    J Surg Oncol; 2013 Mar; 107(4):360-6. PubMed ID: 22886602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
    Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
    Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
    Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
    Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
    Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
    Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects.
    Chen B; Qiu LX; Li Y; Xu W; Wang XL; Zhao WH; Wu JQ
    Lung Cancer; 2010 Dec; 70(3):247-52. PubMed ID: 20395011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.
    Dai S; Mao C; Jiang L; Wang G; Cheng H
    Hum Genet; 2009 Jun; 125(5-6):633-8. PubMed ID: 19357867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 codon 72 Arg/Pro polymorphism and lung cancer risk in Asians: an updated meta-analysis.
    Wang S; Lan X; Tan S; Wang S; Li Y
    Tumour Biol; 2013 Oct; 34(5):2511-20. PubMed ID: 23812725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis.
    Xu CH; Wang Q; Zhan P; Qian Q; Yu LK
    Mol Biol Rep; 2014 Jul; 41(7):4199-212. PubMed ID: 24566690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between TP53 Arg72Pro polymorphism and lung cancer susceptibility: evidence from 30,038 subjects.
    Qiao Q; Hu W
    Lung; 2013 Aug; 191(4):369-77. PubMed ID: 23595658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians.
    Xu T; Xu ZC; Zou Q; Yu B; Huang XE
    Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XPA A23G polymorphism and lung cancer risk: a meta-analysis.
    Zou JH; An L; Chen S; Ren LQ
    Mol Biol Rep; 2012 Feb; 39(2):1435-40. PubMed ID: 21611749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.